<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Broadridge Transform (tm) - http://www.broadridge.com-->
<!--Created: Wed Aug 26 20:15:37 UTC 2026-->
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/npx eis_NPX_Filer.xsd" xmlns="http://www.sec.gov/edgar/npx" xmlns:common="http://www.sec.gov/edgar/common" xmlns:sccommon="http://www.sec.gov/edgar/sccommon" xmlns:iso="http://www.sec.gov/edgar/iso_statecodes" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>N-PX</submissionType>
    <filerInfo>
      <registrantType>IM</registrantType>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0002055207</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <periodOfReport>06/30/2026</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <yearOrQuarter>YEAR</yearOrQuarter>
      <reportCalendarYear>2026</reportCalendarYear>
      <reportingPerson>
        <name>Gilead Therapeutics A1 Unlimited Co</name>
        <phoneNumber>353-21-482-5500</phoneNumber>
        <address>
          <common:street1>IDA BUSINESS &amp; TECHNOLOGY PARK</common:street1>
          <common:street2>CARRIGTOHILL</common:street2>
          <common:city>CORK</common:city>
          <common:stateOrCountry>L2</common:stateOrCountry>
          <common:zipCode>T45 DP77</common:zipCode>
        </address>
      </reportingPerson>
      <agentForService>
        <name>Aoife Marrinan</name>
        <address>
          <common:street1>IDA BUSINESS &amp; TECHNOLOGY PARK</common:street1>
          <common:street2>CARRIGTOHILL</common:street2>
          <common:city>CORK</common:city>
          <common:stateOrCountry>L2</common:stateOrCountry>
          <common:zipCode>T45 DP77</common:zipCode>
        </address>
      </agentForService>
      <reportInfo>
        <reportType>INSTITUTIONAL MANAGER NOTICE REPORT</reportType>
        <noticeExplanation>REPORTING PERSON DID NOT EXERCISE VOTING</noticeExplanation>
        <confidentialTreatment>N</confidentialTreatment>
      </reportInfo>
      <fileNumber>028-25083</fileNumber>
      <explanatoryInformation>
        <explanatoryChoice>N</explanatoryChoice>
      </explanatoryInformation>
    </coverPage>
    <!--[WMV7][kHodOLISfMzvuwSEGK16rkMiNnoeCUBArajlva7c5pFAALcwjoAtG/+Rg4y+/L+jgtAlaAwWGheJmRGWX3zN3qB+UdiYKuGCjTgEwRMLJD7nhDxrHNJQzCJn4orWWx5curhT6MDk04Z4xSv+aRdAF0cGwAvzLiwZesU2QgHw2oHgPYdTpVNuX/lGj32VPWlpbWYoENH9gfOJfJ3hzcZWVz/gC7/qN226YVA5Mke15pnSqbkJuauqcHTm3T1pcKIo3N230qPZIG1sa2D7pjavoo/Fny1g5xhc3w9mowNuOfpQqszWKEQMVmZMi6YEEl+WClPiom+GxTBb] CSR-->
    <signaturePage>
      <reportingPerson>Gilead Therapeutics A1 Unlimited Co</reportingPerson>
      <txSignature>Aoife Marrinan</txSignature>
      <txPrintedSignature>Aoife Marrinan</txPrintedSignature>
      <txTitle>Director</txTitle>
      <txAsOfDate>08/26/2026</txAsOfDate>
    </signaturePage>
  </formData>
</edgarSubmission>
